A labor and delivery nurse is orienting a newly hired nurse and is educating her on contraindications for vaginal exams. In which of the following scenarios is a vaginal exam contraindicated?

A. Vaginal discharge should be assessed to monitor the amount, color, and odor of the amniotic fluid, which can provide information about membrane rupture and possible infection. However, this assessment is secondary to fetal well-being. While it is important to note whether the fluid is clear, meconium-stained, or foul-smelling, it does not provide immediate information about fetal compromise, making it less urgent than FHR assessment.

B. Bladder distention can interfere with labor progression by preventing fetal descent and may require catheterization. Although important during labor management, bladder assessment is not time-critical immediately after amniotomy, and addressing it does not take priority over detecting potential fetal compromise.

C. Maternal blood pressure is routinely monitored to assess maternal cardiovascular status and detect hypertensive disorders such as preeclampsia. While maternal stability is important, unless the mother has known hypertension or symptoms of hypotension, it is not the most urgent assessment immediately after membrane rupture.

D. Fetal heart rate pattern is the priority assessment immediately after amniotomy. Artificial rupture of membranes can increase the risk of umbilical cord prolapse, cord compression, or sudden changes in amniotic fluid volume, all of which can compromise fetal oxygenation. Continuous FHR monitoring allows the nurse to detect variable decelerations, bradycardia, or other signs of fetal distress immediately, enabling prompt interventions such as maternal repositioning, oxygen administration, or notifying the healthcare provider. Monitoring FHR first ensures immediate fetal safety, which is the most critical concern following an amniotomy.

A. While assessing temperature is important for evaluating maternal infection or overall condition, it is not the primary concern when administering magnesium sulfate. Fever does not typically indicate magnesium toxicity, so it is not the priority assessment in this situation.

B. This is the priority assessment because magnesium sulfate can cause respiratory depression if serum levels exceed the therapeutic range. Magnesium acts as a central nervous system depressant and smooth muscle relaxant, which helps inhibit uterine contractions in preterm labor but also poses a risk to respiratory function. The nurse should assess the client’s respiratory rate before initiating the infusion and monitor continuously throughout therapy. A respiratory rate below 12 breaths per minute may indicate early magnesium toxicity, necessitating immediate cessation of the infusion, administration of calcium gluconate as an antidote, and supportive respiratory care.

C. Monitoring blood pressure is important, especially in clients with preeclampsia, because magnesium sulfate can have mild hypotensive effects. However, the most immediate risk of toxicity is respiratory depression, not blood pressure changes. Therefore, while BP is monitored, it is secondary to respiratory assessment in this context.

D. Bowel sounds are part of a routine assessment but are not affected by magnesium sulfate and do not relate to the medication’s most dangerous complications.